Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Farmers Insurance
US Department of Justice
Harvard Business School
Chinese Patent Office
Argus Health

Generated: September 19, 2017

DrugPatentWatch Database Preview

Prednisolone tebutate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for prednisolone tebutate and what is the scope of prednisolone tebutate patent protection?

Prednisolone tebutate
is the generic ingredient in two branded drugs marketed by Merck and Watson Labs, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are eighty-six drug master file entries for prednisolone tebutate.

Summary for Generic Name: prednisolone tebutate

Drug Master File Entries: see list86
Bulk Api Vendors: see list8
Clinical Trials: see list419
Patent Applications: see list1,488
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:prednisolone tebutate at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
prednisolone tebutate
INJECTABLE;INJECTION083362-001Feb 17, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
prednisolone tebutate
INJECTABLE;INJECTION010562-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
US Army
Chinese Patent Office
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus